| Name | Title | Contact Details |
|---|
At Clarify, we are improving the lives of patients and those who care for them by building the brains of the digital healthcare system of the future. We partner with forward-looking providers and payers to optimize episode workflows, improve patient experience, increase volume, and maximize bonuses. We deliver innovative digital and analytics solutions that enable patients to obtain, and our customers to deliver, more satisfying, better outcome, higher value healthcare.
Young Dental Laboratory Inc. is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medpricer empowers industry-leading sourcing teams To help you with the continued pressure to optimize healthcare costs, our expert team and best-in-class technology triples your internal sourcing capacity and helps you cut purchased services expenses by an average of 24% without costing you a dime. You lead – We empower You retain the control of your goals and decisions. With the Medpricer methodology and $2.7 billion of Purchased Services sourcing experience, you extend your sourcing capability upfront and establish a best-in-class infrastructure to drive ongoing success in the future. Process more than you ever imagined We discover and optimize every Purchased Service category in your organization. Built on a time-tested methodology, our industry-leading custom contracting platform helps organizations consolidate spend data and manage negotiations more. Your GPO can`t help you like we can We give your team the expertise and flexibility of a consultant with the scalability of a GPO. Access our vendor-paid, independent custom contracting system to secure the right terms at the right price for all of your 400+ Purchased Service categories.
Central Medical Equipment Rentals is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.